NASDAQ$HCAT

Health Catalyst Inc · Q3 2018 earnings

Q3 2018 earnings · · Investor relations

Headline financials

Total Revenue

$32.9M

No prior period
EPS (adj)

-$0.61

No prior period
Net Income

-$16.9M

No prior period
Operating Income

-$16.5M

No prior period
Gross Profit

$15.9M

No prior period
R&D Expense

$10.8M

No prior period

Revenue & EPS history

Health Catalyst · Revenue · Quarterly

$32.9M

Q3 2018
Beat estimate in 4 of 12 quarters(33%)
ActualEstimate

Revenue by segment

Health Catalyst · $73.8M total across 2 segments · Q3 2023

  • Technology
    $46M+4.5%
  • Professional Services
    $27.8M+14.1%

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

-3.1%

Avg return

Earnings day

-3.9%

Avg return

5 days after

-4.0%

Avg return

30 days after

41%

11 / 27 earnings

Positive

+27.3%

Q2 2024

Best reaction

-36.6%

Q2 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-9.9%-21.7%+4.6%
Q4 2025-26.3%-35.2%-44.4%
Q3 2025-5.6%-20.5%-10.2%
Q1 2025+5.3%+8.1%+3.3%
Q4 2024-11.1%-8.5%-7.9%
Q3 2024+14.2%+7.2%+7.6%
Q2 2024+27.3%+7.3%+22.9%
Q1 2024-3.6%+2.9%-2.3%
Q4 2023-14.7%-8.9%-14.4%
Q3 2023+5.1%-0.4%+5.3%
Q2 2023-8.0%-5.0%-12.4%
Q1 2023-18.9%-14.8%-4.3%
Q4 2022+7.3%+5.8%-14.8%
Q3 2022+16.2%+42.9%+59.2%
Q2 2022-36.6%-34.7%-35.9%
Q1 2022-2.6%+24.6%+10.5%
Q4 2021+1.5%-7.1%-3.7%
Q3 2021-6.2%-6.1%-26.9%
Q2 2021+1.5%-2.3%-2.8%
Q1 2021-2.3%-8.6%-2.4%
Q4 2020+0.6%+0.1%-2.1%
Q3 2020-0.2%-3.5%+6.2%
Q2 2020-7.2%-10.9%-3.4%
Q1 2020-1.9%-0.5%-5.0%
Q4 2019+1.3%-5.8%-20.1%
Q3 2019+1.9%-0.8%-1.1%
Q2 2019-11.5%-7.8%-13.1%
Q4 2018
Q3 2018
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro